BLLXF - Sire Bioscience Inc.

Other OTC - Other OTC Delayed Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
2019-03-30
2018-03-30
2017-03-30
2016-03-30
Total Revenue
125
125
50
0
2
Cost of Revenue
-
-
-
-
-
Gross Profit
-
-
-
-
-
Operating Expenses
Research Development
37
52
86
1
162
Selling General and Administrative
1,318
1,828
285
142
178
Total Operating Expenses
1,355
1,881
371
143
339
Operating Income or Loss
-1,230
-1,756
-321
-143
-338
Interest Expense
-
-
-
-
-
Total Other Income/Expenses Net
-72
-131
42
0
0
Income Before Tax
-1,298
-1,884
-276
-142
-336
Income Tax Expense
-
-
-
-
-
Income from Continuing Operations
-1,298
-1,884
-276
-142
-336
Net Income
-1,298
-1,884
-276
-142
-336
Net Income available to common shareholders
-1,298
-1,884
-276
-142
-336
Reported EPS
Basic
-
-0.02
-0.01
-0.01
-0.01
Diluted
-
-0.02
-0.01
-0.01
-0.01
Weighted average shares outstanding
Basic
-
108,265
44,408
30,345
29,177
Diluted
-
108,265
44,408
30,345
29,177
EBITDA
-
-1,756
-321
-143
-338